NYSE:MYOV
Delisted

Myovant Sciences Stock Signals

etoro logo Buy MYOV
*Your capital is at risk
$26.98
+0 (+0%)
At Close: Jun 08, 2023

Latest Data & Signals Issued

Below are some of the latest signals issued for Myovant Sciences Ltd

General

Signal Type Signal Value Data
Score 0.000 85 days ( -0.260 %
Last Price $26.98 0 %
Performance History
7 Days
$26.98 $26.98
0%
30 Days
$26.98 $26.98
0%
12 Mos
$12.80 $26.98
110.78%

4/18

Active Buy Signals

Specific Signals

Short Term
Net score: 15.54
Signal Type Signal Value Importance Data
High / Low N/A Very Low $26.98 - $26.98
Trend - 3 mos 0 % High Width: 0 %
Pred. range - 3 mos N/A - N/A Low -100.00 % - -100.00 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Jun 07, 2023 - 2 days
RSI Short Pivot Signal Sell Very Low Mar 23, 2023 - 54 days
Short MA 3 mos Sell Low Mar 15, 2023 - 60 days
Long MA 3 mos Sell Medium Apr 25, 2023 - 32 days
Short/Long MA 3 mos Sell Medium Apr 25, 2023 - 32 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 46.06
Signal Type Signal Value Importance Data
Trend - 12 mos 80.11 % Very High Width: 40.70 %
Pred. range - 12 mos $46.76 - $65.79 High 73.32 % - 143.85 %
Short MA 12 mos Sell Very High Mar 22, 2023 - 55 days
Long MA 12 mos Sell Very High Jul 21, 2022 - 223 days
Short/Long MA 12 mos Buy Very High Jun 22, 2022 - 243 days
Pivot Long Sell Low Dec 22, 2022 - 115 days
RSI Long Pivot Signal Sell Low Apr 03, 2023 - 47 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT MYOVANT SCIENCES LTD
Myovant Sciences
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain, and advanced prostate cancer. It is also developing MVT-602, an oligopeptide kisspeptin agonist, whic...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
7.76% Jun 12
DHI
$146.71
7.57% Jun 10
PHM
$118.49
7.15% Jun 10
EAT
$140.46
17.39% Jun 05
TPR
$140.47
2.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE